Wedge Capital Management’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-12,102
Closed -$693K 575
2018
Q2
$693K Sell
12,102
-2,696
-18% -$142K 0.01% 426
2018
Q1
$682K Hold
14,798
0.01% 416
2017
Q4
$683K Buy
14,798
+490
+3% +$22.5K 0.01% 416
2017
Q3
$644K Buy
14,308
+1,716
+14% +$73.2K 0.01% 421
2017
Q2
$495K Buy
12,592
+28
+0.2% +$1.06K ﹤0.01% 446
2017
Q1
$479K Buy
+12,564
New +$490K ﹤0.01% 441

Other funds holding AVNS

Wedge Capital Management's AVNS Position: Q3 2018 in Review

Wedge Capital Management sold out of Avanos Medical (AVNS) in Q3 2018, closing a stake of 12,102 shares — an estimated $693K sold.

Wedge Capital Management first reported a position in AVNS in Q1 2017 and held it in 6 quarters. The position peaked at $693K in Q2 2018. 387 funds tracked by Wall St. Rank hold AVNS as of Q3 2018.

  • Wedge Capital Management reported no remaining Avanos Medical position as of Q3 2018 after selling out during the quarter.
  • Wedge Capital Management sold 12,102 Avanos Medical shares in Q3 2018, an estimated $693K.
  • Wedge Capital Management first reported a position in Avanos Medical in Q1 2017 and held it in 6 quarters.
  • Wedge Capital Management's Avanos Medical position peaked at $693K in Q2 2018.
  • 387 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2018.

Based on Wedge Capital Management's 13F filing for Q3 2018, filed 1 Nov 2018.